Community/Retail

The HIV treatment update includes more considerations for coinfected patients and pregnant women than the previously published 2011 guidelines.

The guidelines provide a few updates to the pharmacologic management of the disease.

The live varicella-zoster vaccine is adequately immunogenic in patients with rheumatoid arthritis starting treatment with tofacitinib, according to results of a recently-published study in Arthritis & Rheumatology.

Dr. David Singer discusses why he pursued the fellowship at Thomas Jefferson University in the College of Population Health and Janssen Scientific Affairs, LLC.

Insights into possible treatments for disorders that range from demyelination to plaque formation and misfolded proteins.

Find out what you have to do and work hard until you get it.

One of the biggest struggles that patients face is ensuring that they have the proper medications on hand and are taking their medications correctly.

FDA officials noted that the human insulin analog met all necessary regulatory requirements for approval, but the approval is tentative pending any patent issues that are yet to be resolved.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

This initiative emphasizes the importance of early recognition and timely treatment of sepsis, as well as the importance of preventing infections that could lead to sepsis.

Human papillomavirus (HPV) vaccine rates are on the rise among US teens but more work is needed to get more teens vaccinated.

Imagine a sense of motivation so great, so powerful, that you literally cannot wait to start your day.

Avella just announced that it has launched a new mobile app aimed at care providers who manage patients dealing with chronic pain or an addiction to pain medication.

Have you ever considered pursuing a PGY-2 pharmacy residency in pain management and palliative care?

More frequent trips to the pharmacy to pick up refills are bad for patients when it comes to birth control. Studies have shown that when patients are given more supplies at a time, they stick to their birth control method for longer and have fewer unintended pregnancies.

There are two recently approved medications for this condition.

Pharmacists may soon be posed to take on new roles within the growing landscape of animal health.

Officials with the FDA have issued a historic approval of the first Chimeric Antigen Receptor (CAR) T-Cell Therapy to be available in the United States.

In MAPS' completed phase 2 trials with 107 participants, 61% no longer qualified for PTSD after 3 sessions of MDMA-assisted psychotherapy 2 months following treatment.

Study examines how a school nursing intervention helped reduce missed school days.

A recently-published study evaluated increasing concerns that plaque psoriasis medications may trigger inflammatory bowel disease (IBD).

It is the first treatment approved in the United States for the treatment of Chagas disease.

Officials with the FDA have announced the approval of Vabomere (Rempex) for the treatment of complicated urinary tract infections (cUTI).

Boehringer said they also plan to seek approval for an auto-injector of the biosimilar to expand options for patients.

There are several roles pharmacists can play in managing patients with cardiovascular disease, including blood pressure and medication monitoring.

The rivaroxaban plus aspirin combination therapy to treat patients with stable coronary or peripheral artery disease showed such benefits in the COMPASS trial that it should become the standard of care.

John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology, discusses the vexing problem of patients who fail to fill or take recommended medications.

Kite's most advanced therapy candidate, axicabtagene ciloleucel (axi-cel), is a CAR T therapy currently under priority review by the US FDA, and is expected to be a treatment option for refractory aggressive non-Hodgkin lymphoma,